Status:

COMPLETED

Sleep, Hypertension, and Nocturia: a Multicomponent Approach for Comorbid Illnesses

Lead Sponsor:

University of Pittsburgh

Collaborating Sponsors:

National Institute on Aging (NIA)

Conditions:

Nocturia

Hypertension

Eligibility:

All Genders

65+ years

Phase:

NA

Brief Summary

In this study the investigators target three common and comorbid illnesses among older adults namely nocturia or waking at night to void, poor sleep and hypertension. The aim of this proposal is to te...

Detailed Description

The investigators posit that a vicious cycle operates between nocturia, poor sleep, and nighttime hypertension (HTN). HTN act through the pressure-natriuresis mechanism that links sodium (Na) and BP h...

Eligibility Criteria

Inclusion

  • The study shall include: ambulatory and functionally-independent community-dwelling men and women aged 65+ years, with
  • nocturia ≥2/night, and
  • history of high blood pressure and receives one or more non-diuretic, once daily antihypertensive- angiotensin converting enzyme inhibitor (ACE-I), angiotensin receptor blocker (ARB), calcium channel blocker (CCB), beta blocker

Exclusion

  • Unstable or acute medical or central nervous system conditions
  • Untreated, current, severe psychiatric condition
  • Untreated, current, severe overactive bladder syndrome
  • Post void residual \> 30ml
  • Montreal cognitive assessment (MOCA) \<26
  • Currently diagnosed and/or treated Obstructive Sleep Apnea, Restless Legs Syndrome, parasomnia
  • Congestive heart failure, by exam
  • Chronic kidney disease, stage III-V (eGFR\<60)
  • \>14 alcohol drinks per week
  • \>3 caffeinated drinks (\~300mg) per day

Key Trial Info

Start Date :

June 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 30 2024

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT05419830

Start Date

June 1 2022

End Date

January 30 2024

Last Update

December 17 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Pittsburgh

Pittsburgh, Pennsylvania, United States, 15213